Coronary Artery Disease and Aortic Valve Stenosis: A Urine Proteomics Study

Luís Perpétuo1,2, António S Barros2, Jéssica Dalsuco2

  • 1iBiMED-Institute of Biomedicine, Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal.

Insights

Researchers identified key urinary proteins, TIMP1, MMP2, and von Willebrand factor (vWF), as potential biomarkers for early detection of coronary artery disease (CAD) and aortic valve stenosis (AVS). These proteins show increased levels in patients and correlate with cardiovascular risk factors.

Area of Science:

  • Cardiovascular Research
  • Proteomics
  • Biomarker Discovery

Background:

  • Coronary artery disease (CAD) and aortic valve stenosis (AVS) are prevalent heart conditions often co-occurring and sharing risk factors and pathogenesis.
  • Early detection of these atherosclerotic diseases is crucial for timely intervention, but routine biomarkers are lacking.
  • Urine offers a noninvasive source for potential biomarker identification.

Purpose of the Study:

  • To identify novel urinary protein biomarkers for the early detection of CAD and/or AVS.
  • To explore the potential of urine proteomics for differentiating patients with these conditions from healthy individuals.

Main Methods:

  • Shotgun proteomics analysis of urine samples from patients with CAD/AVS and healthy controls.
  • Identification and validation of differentially expressed proteins using independent cohorts.
  • Analysis of protein-protein interaction networks and correlation with cardiovascular risk factors.

Main Results:

  • TIMP1, MMP2, and von Willebrand factor (vWF) were significantly elevated (≥2.5×) in the urine of CAD/AVS patients.
  • These proteins occupied central positions in identified protein-protein interaction networks.
  • Urinary TIMP1 and vWF levels strongly correlated with high-density lipoprotein (HDL) cholesterol, a cardiovascular risk factor.

Conclusions:

  • Urinary TIMP1, MMP2, and vWF are promising candidates for noninvasive biomarkers of CAD and AVS.
  • These biomarkers may aid in the early diagnosis and risk stratification of patients with these common heart diseases.
  • Further validation is warranted to establish their clinical utility in routine diagnostics.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
142
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
235
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
71
Imaging Studies I: Kidney, Ureter, and Bladder Studies01:28

Imaging Studies I: Kidney, Ureter, and Bladder Studies

Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
33